IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 127 filers reported holding IDEAYA BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,145,708 | +18.9% | 561,368 | +3.6% | 0.00% | +50.0% |
| Q2 2023 | $12,736,719 | +129.3% | 541,988 | +34.0% | 0.00% | +100.0% |
| Q1 2023 | $5,553,827 | -24.4% | 404,503 | +0.0% | 0.00% | -50.0% |
| Q4 2022 | $7,346,658 | +53.6% | 404,329 | +26.2% | 0.00% | +100.0% |
| Q3 2022 | $4,782,000 | +5.4% | 320,508 | -2.5% | 0.00% | 0.0% |
| Q2 2022 | $4,535,000 | +33.9% | 328,651 | +8.6% | 0.00% | 0.0% |
| Q1 2022 | $3,386,000 | -54.2% | 302,569 | -3.2% | 0.00% | 0.0% |
| Q4 2021 | $7,386,000 | -6.1% | 312,425 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $7,870,000 | +43.7% | 308,744 | +18.3% | 0.00% | 0.0% |
| Q2 2021 | $5,475,000 | +36.9% | 260,874 | +53.3% | 0.00% | 0.0% |
| Q1 2021 | $3,998,000 | +42.4% | 170,145 | -15.1% | 0.00% | 0.0% |
| Q4 2020 | $2,807,000 | +31.1% | 200,445 | +17.6% | 0.00% | – |
| Q3 2020 | $2,141,000 | +16.9% | 170,502 | +32.3% | 0.00% | – |
| Q2 2020 | $1,831,000 | – | 128,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |